US 9650352
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
granted A61KA61K31/135A61K31/137
Quick answer
US patent 9650352 (Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/135, A61K31/137, A61K31/165, A61K31/222